Australia markets closed

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.1700+0.0700 (+6.36%)
As of 11:43AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.1000
Open1.1100
Bid1.1700 x 40700
Ask1.1800 x 36100
Day's range1.1000 - 1.1900
52-week range1.0300 - 2.5450
Volume12,098,367
Avg. volume22,522,344
Market cap2.518B
Beta (5Y monthly)1.42
PE ratio (TTM)N/A
EPS (TTM)-0.4600
Earnings date29 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1.97
  • PR Newswire

    Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments

    Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA's objectives under its new Ice Control for cold Environments (ICE) program.

  • PR Newswire

    AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production

    AQUA Cultured Foods, a food tech company producing alternative seafood options through the use of microbial fermentation, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. AQUA has chosen Ginkgo to help optimize its innovative fermentation technology to elevate the quality of its fish-free seafood products that authentically replicate the look, feel, and taste of fresh-caught seafood. Leveraging Ginkgo

  • PR Newswire

    Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins

    Imagindairy, an Israeli-based foodtech company developing sustainable and commercially viable animal-free dairy proteins, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. Together, Ginkgo and Imagindairy aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner. This collaboration will leverage Ginkgo Protein Expression Services and Imagindair